Research
Multimorbidity, polypharmacy, referrals, and adverse drug events: are we doing things well?
Amaia Calderón-Larrañaga, Beatriz Poblador-Plou, Francisca González-Rubio, Luis Andrés Gimeno-Feliu, José María Abad-Díez and Alexandra Prados-Torres
British Journal of General Practice 2012; 62 (605): e821-e826. DOI: https://doi.org/10.3399/bjgp12X659295
Amaia Calderón-Larrañaga
PhD
Roles: researcher
Beatriz Poblador-Plou
MPH
Roles: researcher
Francisca González-Rubio
MD, GP
Roles: Aragón Health Sciences Institute (IACS)
Luis Andrés Gimeno-Feliu
MD, PhDGP
José María Abad-Díez
MD, PhD
Roles: health inspector
Alexandra Prados-Torres
MD, PhD
Roles: senior researcher
Jump to comment:
No eLetters have been published for this article.
In this issue
British Journal of General Practice
Vol. 62, Issue 605
December 2012
Multimorbidity, polypharmacy, referrals, and adverse drug events: are we doing things well?
Amaia Calderón-Larrañaga, Beatriz Poblador-Plou, Francisca González-Rubio, Luis Andrés Gimeno-Feliu, José María Abad-Díez, Alexandra Prados-Torres
British Journal of General Practice 2012; 62 (605): e821-e826. DOI: 10.3399/bjgp12X659295
Multimorbidity, polypharmacy, referrals, and adverse drug events: are we doing things well?
Amaia Calderón-Larrañaga, Beatriz Poblador-Plou, Francisca González-Rubio, Luis Andrés Gimeno-Feliu, José María Abad-Díez, Alexandra Prados-Torres
British Journal of General Practice 2012; 62 (605): e821-e826. DOI: 10.3399/bjgp12X659295
Jump to section
Keywords
More in this TOC Section
Related Articles
Cited By...
Intended for Healthcare Professionals